Physician profile
Janice E Hodge
NPI 1003803446
$7,391.51
in general payments reported to CMS, 2019-2025
36 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,992 · 2022: $1,003 · 2023: $1,197 · 2024: $2,085 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,221 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,220.78 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,686.47 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,055.40 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Biohaven Pharmaceuticals, INC. | $907.23 | 2021 | |
| Novo Nordisk INC | $760.04 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $337.05 | 2022-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $304.94 | 2021-2025 | Prolia, Evenity, Krystexxa |
| Pfizer INC. | $265.54 | 2021-2025 | |
| Inspire Medical Systems, INC. | $253.37 | 2023-2025 | Inspire |
| Astellas Pharma US INC | $199.11 | 2022-2024 | Veozah |
| Exact Sciences Corporation | $176.11 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $138.48 | 2021-2023 | Trintellix |
| Merck Sharp & Dohme LLC | $135.20 | 2021-2024 | Belsomra, Gardasil, Capvaxive |
| Biohaven Pharmaceutical Holding Company LTD. | $120.92 | 2022 | |
| Amarin Pharma, INC. | $115.98 | 2021-2022 | |
| Lilly USA, LLC | $103.22 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $82.52 | 2022-2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $80.48 | 2023 | Sunosi |
| Daiichi Sankyo INC. | $70.84 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $70.34 | 2021-2022 | |
| Aerin Medical INC. | $59.35 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.58 | 2021-2024 | Jardiance, Synjardy |
| Boston Scientific Corporation | $57.71 | 2024 | Wavewriter Alpha Prime 16 |
| Philips North America LLC | $53.87 | 2023 | |
| Medtronic, INC. | $35.18 | 2023 | Interstim |
| Janssen Pharmaceuticals, INC | $34.20 | 2021-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $30.13 | 2023 | Ultomiris |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $29.58 | 2025 | Caplyta |
| Bausch Health US, LLC | $24.45 | 2023 | Aplenzin |
| Sunovion Pharmaceuticals INC. | $23.89 | 2022 | |
| Eisai INC. | $21.88 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.93 | 2021 | |
| Corcept Therapeutics | $19.43 | 2024 | Korlym |
| Esperion Therapeutics, INC. | $17.39 | 2021 | |
| Genentech USA, INC. | $16.45 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.46 | 2021 | |
| Antares Pharma, INC. | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Hodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.